Search

everythinglearnresearchcommunity

for

Search:↓

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Topical minoxidil successfully treated temporal triangular alopecia.

New treatments for hair loss may target specific pathways and generate new hair follicles.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Chinese medicine may help treat hair loss by affecting genes and enzyme activity.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Microneedling with either platelet-rich plasma or 5% minoxidil can increase hair growth in people with androgenetic alopecia, but minoxidil might be slightly better.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

A 17-year-old boy with Temporal Triangular Alopecia successfully grew new hair after a hair restoration surgery using follicular unit transplantation.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.